AARD

AARDVARK THERAPEUTICS INC

AARD·002942100·US·Common Stock·Healthcare - Biotechnology-13D/G

AARD (AARDVARK THERAPEUTICS INC) is held by 45 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($7.4M), VANGUARD CAPITAL MANAGEMENT LLC ($3.2M), AQR CAPITAL MANAGEMENT LLC ($2.8M). Net institutional sentiment: Mixed.

45
Holders
(4 Elite)
$22.8M
Total Value
40% (57)
Consensus
23 buying - 34 selling
13F: Insider & Congress: Updated regularly
AARD

Smart Money Verdict

View all
Loading verdict
Held by 45 funds
4 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Dec 12, 2025 · Activists May 15, 2025 · Congress none

InsiderSNSun NelsonBuy $43KDec 11, 2025
InsiderLTLee Tien-LiBuy $101KDec 11, 2025
InsiderLTLee Tien-LiBuy $35KSep 15, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.3M(+3.3%)$7.4M0.0%-15.28%
28
Increased
562,877(+1.6%)$3.2M0.0%+38.60%
27
Increased
480,249(+257.1%)$2.8M0.0%+23.39%
42
Unchanged
300,000$1.7M0.0%+38.98%
0
Decreased
187,045(-76.4%)$1.1M0.0%-48.06%
0
Decreased
149,844(-51.6%)$863,5290.0%-43.17%
0
Increased
116,582(+74.8%)$671,5120.0%-14.12%
37
Decreased
108,377(-33.7%)$624,2520.0%-41.51%
0
Increased
79,284(+628.0%)$456,6760.0%+20.70%
39
Decreased
75,172(-9.7%)$432,9910.0%+38.98%
0
Unchanged
72,429$417,1910.0%+38.98%
0
Decreased
69,948(-28.9%)$402,9000.0%-49.66%
0
Decreased
59,273(-70.3%)$341,4120.0%-41.64%
0
Increased
38,382(+132.8%)$221,0800.0%+26.33%
37
Decreased
35,639(-77.4%)$205,2810.0%+11.87%
0
Increased
30,177(+71.8%)$173,8200.0%-33.39%
23
Decreased
28,080(-68.3%)$161,7410.0%-45.46%
0
Decreased
26,299(-43.2%)$151,4820.0%+34.53%
0
Decreased
24,033(-44.4%)$138,4300.0%+38.98%
0
New
24,025$138,3840.0%+18.23%
34

Showing 1-20 of 61

1 / 4
AARDAARDAARDVARK THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used